Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

NCT02231255 · clinicaltrials.gov ↗

COMPLETED

Status

1216

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Sifrol®

Sponsor

Boehringer Ingelheim